Cameron Durrant, Humanigen CEO (Columbia University Technology Ventures via YouTube)
Humanigen crashes as FDA shoots down its Covid-19 drug EUA
Humanigen, once led by the imprisoned Martin Shkreli, is finding itself in a similarly confined space.
On Thursday, the company said the FDA declined its request for an EUA for its lead drug lenzilumab to treat newly hospitalized Covid-19 patients, sending shares of the company’s stock $HGEN down by more than 50% pre-market.
Why exactly the FDA rejected the EUA remains largely unknown as the company offered few specifics.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
